| · Журналы
· Книги
· О проекте
·Электронные версии книг издательства “Атмосфера” поступили в продажу
Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания.
Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru
ИНТЕРНЕТ-МАГАЗИН
|
|
 | |
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2023 / N 2
Экстрапульмональные поражения у пациентов с орфанными заболеваниями легких
А.Н. Баранова, А.В. Абраменко, О.А. Георгинова, Л.Я. Французевич, Т.Н. Краснова
Список литературы
1. Alfaro TM, Wijsenbeek MS, Powell P, Stolz D, Hurst JR, Kreuter M, Moor CC. Educational aspects of rare and orphan lung diseases. Respiratory Research 2021 Mar;22(1):92.
2. Wijsenbeek M, Humbert M, Wagner T, Kreuter M. The flare of care for rare: per aspera ad astra for rare lung diseases! European Respiratory Review 2023 Feb;32(167):230006.
3. EURORDIS. Rare Disease Europe. Who we are. Available from: www.eurordis.org/who-we-are/our-vision-mission/ Accessed 2023 Oct 05.
4. European Commission. Public Health. Orphan medical products. Available from: https://health.ec.europa.eu/medicinal-products/orphan-medicinal-products_en Accessed 2023 Oct 05.
5. Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine 2013 Sep;188(6):733-48.
6. Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, Hubbard RB. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 2011 Jun;66(6):462-7.
7. Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ. Idiopathic pulmonary fibrosis: disease mechanisms and drug development. Pharmacology & Therapeutics 2021 Jun;222:107798.
8. Luppi F, Kalluri M, Faverio P, Kreuter M, Ferrara G. Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management. Respiratory Research 2021 Apr;22(1):109.
9. Spagnolo P, Cottin V. Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine. Journal of Medical Genetics 2017 Feb;54(2):93-9.
10. Bellaye PS, Kolb M. Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis. BMC Medicine 2015 Sep;13:176.
11. Armanios M. Telomerase and idiopathic pulmonary fibrosis. Mutation Research 2012 Feb;730(1-2):52-8.
12. Kreuter M, Ehlers-Tenenbaum S, Palmowski K, Bruhwyler J, Oltmanns U, Muley T, Heussel CP, Warth A, Kolb M, Herth FJ. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One 2016 Mar;11(3):e0151425.
13. Kizer JR, Zisman DA, Blumenthal NP, Kotloff RM, Kimmel SE, Strieter RM, Arcasoy SM, Ferrari VA, Hansen-Flaschen J. Association between pulmonary fibrosis and coronary artery disease. Archives of Internal Medicine 2004 Mar;164(5):551-6.
14. Agrawal A, Verma I, Shah V, Agarwal A, Sikachi RR. Cardiac manifestations of idiopathic pulmonary fibrosis. Intractable & Rare Diseases Research 2016 May;5(2):70-5.
15. Navaratnam V, Fogarty AW, McKeever T, Thompson N, Jenkins G, Johnson SR, Dolan G, Kumaran M, Pointon K, Hubbard RB. Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case–control study. Thorax 2014 Mar;69(3):207-15.
16. Dalleywater W, Powell HA, Fogarty AW, Hubbard RB, Navaratnam V. Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study. The European Respiratory Journal 2014 Dec;44(6):1714-5.
17. Newton CA, Batra K, Torrealba J, Kozlitina J, Glazer CS, Aravena C, Meyer K, Raghu G, Collard HR, Garcia CK. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. The European Respiratory Journal 2016 Dec;48(6):1710-20.
18. Ikezoe K, Handa T, Tanizawa K, Kubo T, Oguma T, Hamada S, Watanabe K, Aihara K, Sokai A, Nakatsuka Y, Muro S, Nagai S, Uno K, Chin K, Fukui M, Hirai T, Mishima M. Bone mineral density in patients with idiopathic pulmonary fibrosis. Respiratory Medicine 2015;109(9):1181-7.
19. Caffarelli C, Gonnelli S, Tomai Pitinca MD, Francolini V, Fui A, Bargagli E, Refini RM, Bennett D, Nuti R, Rottoli P. Idiopathic pulmonary fibrosis a rare disease with severe bone fragility. Internal and Emergency Medicine 2016 Dec;11(8):1087-94.
20. Enomoto T, Usuki J, Azuma A, Nakagawa T, Kudoh S. Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis. Chest 2003 Jun;123(6):2007-11.
21. Oldham JM, Kumar D, Lee C, Patel SB, Takahashi-Manns S, Demchuk C, Strek ME, Noth I. Thyroid disease is prevalent and predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2015 Sep;148(3):692-700.
22. Alder JK, Guo N, Kembou F, Parry EM, Anderson CJ, Gorgy AI, Walsh MF, Sussan T, Biswal S, Mitzner W, Tuder RM, Armanios M. Telomere length is a determinant of emphysema susceptibility. American Journal of Respiratory and Critical Care Medicine 2011 Oct;184(8):904-12.
23. Tobin RW, Pope CE 2nd, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 1998 Dec;158(6):1804-8.
24. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. American Journal of Respiratory and Critical Care Medicine 2000 Jan;161(1):5-8.
25. Ozawa Y, Suda T, Naito T, Enomoto N, Hashimoto D, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Chida K. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology (Carlton, Vic.) 2009 Jul;14(5):723-8.
26. Nathan N, Giraud V, Picard C, Nunes H, Dastot-Le Moal F, Copin B, Galeron L, De Ligniville A, Kuziner N, Reynaud-Gaubert M, Valeyre D, Couderc LJ, Chinet T, Borie R, Crestani B, Simansour M, Nau V, Tissier S, Duquesnoy P, Mansour-Hendili L, Legendre M, Kannengiesser C, Coulomb-L’Hermine A, Gouya L, Amselem S, Clement A. Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer. Human Molecular Genetics 2016 Apr;25(8):1457-67.
27. Stefania C, Angela B, Stefania C, Antonio C, Andrea AS, Gianrocco M, Tiziana S, Luca RB. Idiopathic pulmonary fibrosis and intestinal disorders: an observational study. Annals of Diagnostic Pathology 2023 Feb;62:152072.
28. Kosciuk P, Meyer C, Wikenheiser-Brokamp KA, McCormack FX. Pulmonary alveolar microlithiasis. European Respiratory Review 2020 Nov;29(158):200024.
29. Castellana G, Castellana G, Gentile M, Castellana R, Resta O. Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide. European Respiratory Review 2015 Dec;24(138):607-20.
30. Sabbagh Y, O’Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC. Intestinal npt2b plays a major role in phosphate absorption and homeostasis. Journal of the American Society of Nephrology 2009 Nov;20(11):2348-58.
31. Enemark A, Jönsson ÅLM, Kronborg-White S, Bendstrup E. Pulmonary alveolar microlithiasis – a review. The Yale Journal of Biology and Medicine 2021 Dec;94(4):637-44.
32. Mascie-Taylor BH, Wardman AG, Madden CA, Page RL. A case of alveolar microlithiasis: observation over 22 years and recovery of material by lavage. Thorax 1985 Dec;40(12):952-3.
33. Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H, Yildirim Z, Gocmen A, Tolun A. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. American Journal of Human Genetics 2006 Oct;79(4):650-6.
34. Arslan A, Yalin T, Akan H, Belet U. Pulmonary alveolar microlithiasis associated with calcifications in the seminal vesicles. Journal Belge de Radiologie 1996 Jun;79(3):118-9.
35. Castellana G, Carone D, Castellana M. Microlithiasis of seminal vesicles and severe oligoasthenospermia in pulmonary alveolar microlithiasis (PAM): report of an unusual sporadic case. International Journal of Fertility and Sterility 2015 Apr-Jun;9(1):137-40.
36. Kanat F, Teke T, Imecik O. Pulmonary alveolar microlithiasis with epididymal and periurethral calcifications causing obstructive azospermia. The International Journal of Tuberculosis and Lung Disease 2004 Oct;8(10):1275.
37. Emri S, Cöplü L, Selçuk ZT, Sahin AA, Baris YI. Hypertrophic pulmonary osteoarthropathy in a patient with pulmonary alveolar microlithiasis. Thorax 1991 Feb;46(2):145-6.
38. Jouneau S, Ménard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology (Carlton, Vic.) 2020 Aug;25(8):816-26.
39. Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, Wang T, Morgan C, Cottin V, McCarthy C. Pulmonary alveolar proteinosis. Nature Reviews. Disease Primers 2019 Mar;5(1):16.
40. Hildebrandt J, Yalcin E, Bresser HG, Cinel G, Gappa M, Haghighi A, Kiper N, Khalilzadeh S, Reiter K, Sayer J, Schwerk N, Sibbersen A, Van Daele S, Nübling G, Lohse P, Griese M. Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis. Orphanet Journal of Rare Diseases 2014 Nov;9:171.
41. Ishii H, Seymour JF, Tazawa R, Inoue Y, Uchida N, Nishida A, Kogure Y, Saraya T, Tomii K, Takada T, Itoh Y, Hojo M, Ichiwata T, Goto H, Nakata K. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan. BMC Pulmonary Medicine 2014 Mar;14:37.
42. Schiavina M, Di Scioscio V, Contini P, Cavazza A, Fabiani A, Barberis M, Bini A, Altimari A, Cooke RM, Grigioni WF, D’Errico-Grigioni A. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. American Journal of Respiratory and Critical Care Medicine 2007 Jul;176(1):96-8.
43. Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. The New England Journal of Medicine 1990 Nov;323(18):1254-60.
44. Almoosa KF, Ryu JH, Mendez J, Huggins JT, Young LR, Sullivan EJ, Maurer J, McCormack FX, Sahn SA. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest 2006 May;129(5):1274-81.
45. Ryu JH, Moss J, Beck GJ, Lee JC, Brown KK, Chapman JT, Finlay GA, Olson EJ, Ruoss SJ, Maurer JR, Raffin TA, Peavy HH, McCarthy K, Taveira-Dasilva A, McCormack FX, Avila NA, Decastro RM, Jacobs SS, Stylianou M, Fanburg BL; NHLBI LAM Registry Group. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. American Journal of Respiratory and Critical Care Medicine 2006 Jan;173(1):105-11.
46. Gupta N, Finlay GA, Kotloff RM, Strange C, Wilson KC, Young LR, Taveira-DaSilva AM, Johnson SR, Cottin V, Sahn SA, Ryu JH, Seyama K, Inoue Y, Downey GP, Han MK, Colby TV, Wikenheiser-Brokamp KA, Meyer CA, Smith K, Moss J, McCormack FX; ATS Assembly on Clinical Problems. Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An Official American Thoracic Society/Japanese Respiratory Society clinical practice guideline. American Journal of Respiratory and Critical Care Medicine 2017 Nov;196(10):1337-48.
47. Taveira-DaSilva AM, Jones AM, Julien-Williams P, Yao J, Stylianou M, Moss J. Severity and outcome of cystic lung disease in women with tuberous sclerosis complex. The European Respiratory Journal 2015 Jan;45(1):171-80.
48. Avila NA, Dwyer AJ, Murphy-Johnson DV, Brooks P, Moss J. Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size. AJR. American Journal of Roentgenology 2005 Feb;184(2):459-64.
49. Gao L, Yue MM, Davis J, Hyjek E, Schuger L. In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor. Virchows Archiv 2014 Apr;464(4):495-503.
50. Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM. Identification of intragenic deletions and duplication in the FLCN gene in Birt–Hogg–Dubé syndrome. Genes, Chromosomes & Cancer 2011 Jun;50(6):466-77.
51. Schmidt LS, Linehan WM. Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome. Nature Reviews. Urology 2015 Oct;12(10):558-69.
52. Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt–Hogg–Dubé syndrome. The American Journal of Human Genetics 2005 Jan;76(6):1023-33.
53. Houweling AC, Gijezen LM, Jonker MA, van Doorn MB, Oldenburg RA, van Spaendonck-Zwarts KY, Leter EM, van Os TA, van Grieken NC, Jaspars EH, de Jong MM, Bongers EM, Johannesma PC, Postmus PE, van Moorselaar RJ, van Waesberghe JH, Starink TM, van Steensel MA, Gille JJ, Menko FH. Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. British Journal of Cancer 2011 Dec;105(12):1912-9.
54. van de Beek I, Glykofridis IE, Wolthuis RMF, Gille HJJP, Johannesma PC, Meijers-Heijboer HEJ, Moorselaar RJAV, Houweling AC. No evidence for increased prevalence of colorectal carcinoma in 399 Dutch patients with Birt–Hogg–Dubé syndrome. British Journal of Cancer 2020 Feb;122(4):590-4.
55. Vassallo R, Harari S, Tazi A. Current understanding and management of pulmonary Langerhans cell histiocytosis. Thorax 2017 Oct;72(10):937-45.
56. Collin M, Bigley V, McClain KL, Allen CE. Cell(s) of origin of Langerhans cell histiocytosis. Hematology/Oncology Clinics of North America 2015 Oct;29(5):825-38.
57. Wei P, Lu HW, Jiang S, Fan LC, Li HP, Xu JF. Pulmonary Langerhans cell histiocytosis: case series and literature review. Medicine 2014 Nov;93(23):e141.
58. Lacronique J, Roth C, Battesti JP, Basset F, Chretien J. Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax 1982 Feb;37(2):104-9.
59. Roden AC, Yi ES. Pulmonary Langerhans cell histiocytosis: an update from the pathologists’ perspective. Archives of Pathology & Laboratory Medicine 2016 Mar;140(3):230-40.
60. Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD, Dungu J, Banypersad SM, Wechalekar AD, Whelan CJ, Hawkins PN, Gillmore JD. Systemic amyloidosis in England: an epidemiological study. British Journal of Haematology 2013 May;161(4):525-32.
61. Scala R, Maccari U, Madioni C, Venezia D, La Magra LC. Amyloidosis involving the respiratory system: 5-year’s experience of a multi-disciplinary group’s activity. Annals of Thoracic Medicine 2015 Jul-Sep;10(3):212-6.
62. Третьяков А.Ю., Захарченко С.П., Третьякова В.А. Легочный амилоидоз. Пульмонология 2018;28(1):75-83.
63. Buxbaum JN, Dispenzieri A, Eisenberg DS, Fändrich M, Merlini G, Saraiva MJM, Sekijima Y, Westermark P. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid 2022 Dec;29(4):213-9.
64. Hui AN, Koss MN, Hochholzer L, Wehunt WD. Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases. Archives of Pathology & Laboratory Medicine 1986 Mar;110(3):212-8.
65. Berk JL, O’Regan A, Skinner M. Pulmonary and tracheobronchial amyloidosis. Seminars in Respiratory and Critical Care Medicine 2002 Apr;23(2):155-65.
66. Vieira IG, Marchiori E, Zanetti G, Cabral RF, Takayassu TC, Spilberg G, Batista RR. Pulmonary amyloidosis with calcified nodules and masses – a six-year computed tomography follow-up: a case report. Cases Journal 2009 Sep;2:6540.
67. Road JD, Jacques J, Sparling JR. Diffuse alveolar septal amyloidosis presenting with recurrent hemoptysis and medial dissection of pulmonary arteries. The American Review of Respiratory Disease 1985 Dec;132(6):1368-70.
68. Pitz MW, Gibson IW, Johnston JB. Isolated pulmonary amyloidosis: case report and review of the literature. American Journal of Hematology 2006 Mar;81(3):212-3.
69. Brill AK, Woelke K, Schädlich R, Weinz C, Laier-Groeneveld G. Tracheobronchial amyloidosis – bronchoscopic diagnosis and therapy of an uncommon disease: a case report. Journal of Physiology and Pharmacology 2007 Nov;58 Suppl 5(Pt 1):51-5.
70. Kirbaş G, Dağli CE, Tanrikulu AC, Yildiz F, Bükte Y, Senyiğit A, Kiyan E. Unusual combination of tracheobronchopathia osteochondroplastica and AA amyloidosis. Yonsei Medical Journal 2009 Oct;50(5):721-4.
71. Streeten EA, de la Monte SM, Kennedy TP. Amyloid infiltration of the diaphragm as a cause of respiratory failure. Chest 1986 May;89(5):760-2.
72. Alami B, Maaroufi M. Mounier-Kuhn syndrome. The Pan African Medical Journal 2019 Jul;33:157.
73. Celik B, Bilgin S, Yuksel C. Mounier-Kuhn syndrome: a rare cause of bronchial dilation. Texas Heart Institute Journal 2011;38(2):194-6.
74. Афтаева E.В., Казакова С.С., Крылова Е.А., Плетнева И.А. Компьютерная томография в диагностике синдрома Мунье-Куна. Наука молодых (Eruditio Juvenium) 2021;9(2):267-71.
75. Ayub II, Vengadakrishnan K. Mounier-Kuhn syndrome. Tuberculosis and Respiratory Diseases 2023 Jan;86(1):59-60.
76. Orphanet. Mounier-Kühn syndrome. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng= en&Expert=3347 Accessed 2023 Oct 05.
77. Loued L, Migaou A, Achour A, Ben Saad A, Mhammed SC, Fahem N, Rouatbi N, Joobeur S. Mounier-Kuhn syndrome: a variable course disease. Respiratory Medicine Case Reports 2020 Sep;31:101238.
|
[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ] |
|
|
